Cargando…

The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study

BACKGROUND: The adherence of diabetic patients to their medication regimen is associated with many psychosocial factors that are still unknown. Therefore, the present study aims to identify the psychosocial barriers to medication adherence of patients with type2 diabetes (T2D). METHODOLOGY: This des...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostafavi, Firoozeh, Alavijeh, Fereshteh Zamani, Salahshouri, Arash, Mahaki, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812642/
https://www.ncbi.nlm.nih.gov/pubmed/33461565
http://dx.doi.org/10.1186/s13030-020-00202-x
_version_ 1783637711751479296
author Mostafavi, Firoozeh
Alavijeh, Fereshteh Zamani
Salahshouri, Arash
Mahaki, Behzad
author_facet Mostafavi, Firoozeh
Alavijeh, Fereshteh Zamani
Salahshouri, Arash
Mahaki, Behzad
author_sort Mostafavi, Firoozeh
collection PubMed
description BACKGROUND: The adherence of diabetic patients to their medication regimen is associated with many psychosocial factors that are still unknown. Therefore, the present study aims to identify the psychosocial barriers to medication adherence of patients with type2 diabetes (T2D). METHODOLOGY: This descriptive qualitative study was done in Isfahan, Iran by conducting in-depth unstructured interviews with 23 purposively selected patients with T2D and 10 healthcare providers (HCPs). The participants were interviewed face-to-face between November 2017 and June 2018 at the patient’s home, a Health Care Center, or at the diabetes clinic. Data analysis was performed using MAXQDA-10 software and the conventional content analysis. RESULTS: The analysis of the data led to six categories of perceived psychosocial barriers: 1) fear, concern and distress, 2) exhaustion and burnout, 3) the children’s issues being the priority, 4) poor financial support, 5) communication challenges, and 6) poor work conditions. CONCLUSIONS: This study identified some of the psychosocial barriers to medication adherence of patients with T2D, which will be of great help to researchers and HCPs in designing and implementing effective interventions to overcome these barriers and change patient self-care behaviors and increase their medication adherence.
format Online
Article
Text
id pubmed-7812642
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78126422021-01-19 The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study Mostafavi, Firoozeh Alavijeh, Fereshteh Zamani Salahshouri, Arash Mahaki, Behzad Biopsychosoc Med Research BACKGROUND: The adherence of diabetic patients to their medication regimen is associated with many psychosocial factors that are still unknown. Therefore, the present study aims to identify the psychosocial barriers to medication adherence of patients with type2 diabetes (T2D). METHODOLOGY: This descriptive qualitative study was done in Isfahan, Iran by conducting in-depth unstructured interviews with 23 purposively selected patients with T2D and 10 healthcare providers (HCPs). The participants were interviewed face-to-face between November 2017 and June 2018 at the patient’s home, a Health Care Center, or at the diabetes clinic. Data analysis was performed using MAXQDA-10 software and the conventional content analysis. RESULTS: The analysis of the data led to six categories of perceived psychosocial barriers: 1) fear, concern and distress, 2) exhaustion and burnout, 3) the children’s issues being the priority, 4) poor financial support, 5) communication challenges, and 6) poor work conditions. CONCLUSIONS: This study identified some of the psychosocial barriers to medication adherence of patients with T2D, which will be of great help to researchers and HCPs in designing and implementing effective interventions to overcome these barriers and change patient self-care behaviors and increase their medication adherence. BioMed Central 2021-01-18 /pmc/articles/PMC7812642/ /pubmed/33461565 http://dx.doi.org/10.1186/s13030-020-00202-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mostafavi, Firoozeh
Alavijeh, Fereshteh Zamani
Salahshouri, Arash
Mahaki, Behzad
The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
title The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
title_full The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
title_fullStr The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
title_full_unstemmed The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
title_short The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
title_sort psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812642/
https://www.ncbi.nlm.nih.gov/pubmed/33461565
http://dx.doi.org/10.1186/s13030-020-00202-x
work_keys_str_mv AT mostafavifiroozeh thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy
AT alavijehfereshtehzamani thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy
AT salahshouriarash thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy
AT mahakibehzad thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy
AT mostafavifiroozeh psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy
AT alavijehfereshtehzamani psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy
AT salahshouriarash psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy
AT mahakibehzad psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy